Phase 2 LADDER Results Announced
The use of anti-VEGF therapy has revolutionized the treatment of wet AMD, such that most patients can now maintain functional vision for their lifetimes. However, the need for frequent injections…
The use of anti-VEGF therapy has revolutionized the treatment of wet AMD, such that most patients can now maintain functional vision for their lifetimes. However, the need for frequent injections…
ASRS 2018: Women in Retina (WinR): How to Succeed in Different Practice Environments, From Academia to Private Practice. July 23, 2018. Course Organizer: Audina Berrocal, MD Faculty: Lisa Olmos de…
Durga Borkar, MD Vitreoretinal Surgery Fellow Wills Eye Hospital The session kicked off with Dr. Sengul Ozdek describing the long term anatomical and functional results of surgery for retinal detachment…
Marianeli Rodriguez, MD Vitreoretinal Surgery Fellow Mass Eye & Ear, Harvard Medical School Dr. Geeta Lalwani first discussed the 2-year pooled outcomes from various randomized trials of anti-VEGF treatment for diabetic…
James Lin, MD Vitreoretinal Surgery Fellow Bascom Palmer Eye Institute Dr. Shaileen Parikh started the discussion this morning describing the clinical and OCT findings in chronic solar retinopathy, which is…
Philip Storey, MD, MPH Vitreoretinal Surgery Fellow Mid Atlantic Retina / Wills Eye Hospital Susan Bressler evaluated whether baseline characteristics in the DRCR Protocol S affected outcomes in proliferative diabetic…
Zachary Bodnar, MD Vitreoretinal Surgery Fellow Byers Eye Institute, Stanford University The instrumentation symposium was moderated by Carl Awh, MD and Raymond Iezzi, MD. Kevin Blinder, MD presented initial experiences…
Edward Wood, MD Vitreoretinal Surgery Fellow ARC/Beaumont Following opening comments by Timothy Murray, MD, MBA, the neovascular AMD symposium kicked off an exciting series of symposiums. The section moderated by…